Learn More
BACKGROUND Despite clopidogrel therapy, patients undergoing percutaneous coronary intervention (PCI) with stenting are at risk of recurrent coronary events. This could be partly explained by a(More)
I . BOD O,* J . E IKENBOOM,† R . MONTGOMERY ,‡ J . PATZKE ,§ R . SCHNEPPENHE IM ¶ and J . D I PAOLA ,** ON BEHALF OF THE SUBCOMMITTEE ON VON WILLEBRAND FACTOR *Department of Hematology and Stem Cell(More)